87.56

5.66% 4.69

After Hours: 87.21 -0.35 -0.40%

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Financials Discussions Forecast

Twist Bioscience Corp stock is traded at $87.56, with a volume of 3.94M. It is up +5.66% in the last 24 hours and up +75.86% over the past month. Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Previous Close:

$82.87

Open:

$85.665

24h Volume:

3.94M

Relative Volume:

2.55

Market Cap:

$5.45B

Revenue:

$409.48M

Net Income/Loss:

$-81.28M

P/E Ratio:

-65.90

EPS:

-1.3286

Net Cash Flow:

$-95.14M

1W Performance:

+18.24%

1M Performance:

+75.86%

6M Performance:

+174.31%

1Y Performance:

+143.97%

1-Day Range:

$84.13

$87.77

1-Week Range:

$75.01

$88.46

52-Week Range:

$23.30

$88.46

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1104)

Industry

Diagnostics & Research (49)

Phone

800-719-0671

Address

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Employee

979

Twitter

@TwistBioscience

Next Earnings Date

2026-08-03

Latest SEC Filings

TWST's Discussions on Twitter

Compare TWST vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TWST Twist Bioscience Corp	87.56	5.16B	409.48M	-81.28M	-95.14M	-1.3286
TMO Thermo Fisher Scientific Inc	464.61	171.57B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	177.17	125.81B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	562.09	43.08B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	127.06	35.11B	7.23B	1.41B	1.09B	4.979
WAT Waters Corp	355.44	35.05B	3.77B	449.25M	240.68M	7.8556

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-04-25	Initiated	Stephens	Overweight
Dec-13-24	Initiated	Wolfe Research	Outperform
Jun-04-24	Initiated	Guggenheim	Buy
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

Jun 18, 2026

Twist Bioscience Corp Files For Mixed Shelf - TradingView

Jun 18, 2026

Twist Bioscience (TWST) sets $200M ATM program with TD Cowen - Stock Titan

Jun 18, 2026